EKF Diagnostics Holdings (LSE:EKF) Accounts Payable: £0.75 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:EKF EKF Diagnostics Holdings PLC LSE:EKF
50 GF Score
Price £0.26
GF Value £0.28
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is EKF Diagnostics Holdings Accounts Payable?

EKF Diagnostics Holdings LSE:EKF -1.15% 50 Accounts Payable is £0.75 Mil as of Dec. 2025. GuruFocus rates LSE:EKF with a GF Score™ of 50/100 and a GF Value™ of £0.28 (Fairly Valued). The stock has 4 warning signs investors should review.

EKF Diagnostics Holdings's Accounts Payable for the quarter that ended in Dec. 2025 was £0.75 Mil.

EKF Diagnostics Holdings's quarterly Accounts Payable increased from Dec. 2024 (£0.90 Mil) to Jun. 2025 (£5.79 Mil) but then declined from Jun. 2025 (£5.79 Mil) to Dec. 2025 (£0.75 Mil).

EKF Diagnostics Holdings's annual Accounts Payable declined from Dec. 2023 (£0.98 Mil) to Dec. 2024 (£0.90 Mil) and declined from Dec. 2024 (£0.90 Mil) to Dec. 2025 (£0.75 Mil).

EKF Diagnostics Holdings Accounts Payable Related Terms

EKF Diagnostics Holdings Accounts Payable Historical Data

* Premium members only.

The historical data trend for EKF Diagnostics Holdings's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EKF Diagnostics Holdings Accounts Payable Chart

EKF Diagnostics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.44 1.51 0.98 0.90 0.75

EKF Diagnostics Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 4.84 0.90 5.79 0.75
LSE:EKF
50GF Score
EKF Diagnostics Holdings PLC LSE:EKF
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EKF Diagnostics Holdings Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of £0.75 Mil mean?
EKF Diagnostics Holdings (LSE:EKF) has a Accounts Payable of £0.75 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on EKF Diagnostics Holdings and its competitors.
Is EKF Diagnostics Holdings' Accounts Payable too high?
EKF Diagnostics Holdings' current Accounts Payable is £0.75 Mil. Overall, EKF Diagnostics Holdings has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' Accounts Payable compare to ABT and SYK?
EKF Diagnostics Holdings' Accounts Payable of £0.75 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on EKF Diagnostics Holdings and its competitors. EKF Diagnostics Holdings's current Accounts Payable is £0.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Fairly Valued. The stock's GF Value™ is £0.28, compared to a current price of £0.26 — trading 8.2% below its estimated fair value. The current Accounts Payable is £0.75 Mil. EKF Diagnostics Holdings' overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current Accounts Payable is £0.75 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?

Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued. The current stock price of £0.26 is trading 8.2% below its estimated GF Value™ of £0.28. GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.

Key valuation signals for LSE:EKF:

  • Accounts Payable: £0.75 Mil
  • GF Value™: £0.28 vs. price of £0.26 (8.2% below fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EKF Diagnostics Holdings Business Description

Other Exchanges EKDHF:USALYF:Germany
Address 19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
50GF Score

Get the complete analysis for LSE:EKF

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.26
Price
£0.28
GF Value